Ovarian cancer: New biological markers found that may predict which patients won't respond to chemotherapy
Using a novel proteogenomic strategy and a variety of machine learning tools, investigators from the Icahn School of Medicine at Mount Sinai and colleagues have identified a 64-protein signature that may predict a subset ...